Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
TROY, Mich., Oct. 25, 2016 -- DirectRx Pharmacy, a leading independent pharmacy accredited by URAC, ACHC, NABP and WBENC, has won a competitive bid for nebulizers and related supplies from the Centers for Medicare & Medicaid Services (CMS) under Round 1 2017 of the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) competitive bidding program. The contract will apply from January 1, 2017 through December 31, 2018.
Under the new CMS contract, DirectRx Pharmacy will supply nebulizer equipment and supplies for Medicare clients in Kansas City, Mo. and Dearborn, Franklin, Ohio and Union counties, Ind. DirectRx specializes in treating COPD and other respiratory conditions using integrated care and follow-up, as well as leading medications such as Brovana, Budesonide and Perforomist.
“DirectRx is proud to be awarded this contract so that we can further our vision of helping patients with respiratory conditions such as asthma and COPD,” said Amanda Berishaj, PharmD, of DirectRx. “COPD, chronic bronchitis, emphysema and other respiratory conditions can be treated. With COPD, the key is treating the condition early to improve how well your lungs work.”
The DMEPOS Competitive Bidding Program was mandated by Congress through the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The Centers for Medicare & Medicaid Services, CMS, is part of the Department of Health and Human Services (HHS).
DirectRx Pharmacy, an independent, family-owned pharmacy accredited by URAC, ACHC, NABP and WBENC, is dedicated to providing patients with unparalleled, personalized pharmaceutical care for their specialty pharmacy needs. Unlike other pharmacies, DirectRx is owned and operated by certified doctors of pharmacy. The company has grown to serve more than 38 states since its inception more than two decades ago. Investments in technology help to drive the best possible patient care and deliver the most accurate data to our partners. www.DirectRx.com
CONTACT: Amanda Berishaj, PharmD, DirectRx, (855) 362-3397
